Loading…

Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hürthle cell carcinoma

Abstract Introduction Hürthle cell carcinoma (HCC) is an uncommon thyroid cancer historically considered to be a variant of follicular thyroid carcinoma (FTC). The aim of this study was to assess the differences between these groups in terms of clinical factors and prognoses. Patients and methods A...

Full description

Saved in:
Bibliographic Details
Published in:Endocrinología, diabetes y nutrición. diabetes y nutrición., 2018-03, Vol.65 (3), p.136-142
Main Authors: Ernaga Lorea, Ander, Migueliz Bermejo, Iranzu, Anda Apiñániz, Emma, Pineda Arribas, Javier, Toni García, Marta, Martínez de Esteban, Juan Pablo, Insausti Serrano, Ana María
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Introduction Hürthle cell carcinoma (HCC) is an uncommon thyroid cancer historically considered to be a variant of follicular thyroid carcinoma (FTC). The aim of this study was to assess the differences between these groups in terms of clinical factors and prognoses. Patients and methods A total of 230 patients (153 with FTC and 77 with HCC) with a median follow-up of 13.4 years were studied. The different characteristics were compared using SPSS version 20 statistical software. Results Patients with HCC were older (57.3 ± 13.8 years versus 44.6 ± 15.2 years; p < 0.001). More advanced TNM stages were also seen in patients with HCC and a greater trend to distant metastases were also seen in patients with HCC (7.8% versus 2.7%, p = 0.078). The persistence/recurrence rate at the end of follow-up was higher in patients with HCC (13% versus 3.9%, p = 0.011). However, in a multivariate analysis, only age (hazard ratio [HR] 1.10, confidence interval [CI] 1.04–1.17; p = 0.001), size (HR 1.43, CI 1.05–1.94; p = 0.021), and histological subtype (HR 9.79, CI 2.35–40.81; p = 0.002), but not presence of HCC, were significantly associated to prognosis. Conclusion HCC is diagnosed in older patients and in more advanced stages as compared to FTC. However, when age, size, and histological subtype are similar, disease-free survival is also similar in both groups.
ISSN:2530-0180
2530-0180
DOI:10.1016/j.endien.2017.12.002